IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $123,561 | +10.0% | 2,724 | -0.5% | 0.01% | +16.7% |
| Q2 2023 | $112,299 | +2.2% | 2,737 | -10.9% | 0.01% | 0.0% |
| Q1 2023 | $109,829 | -53.5% | 3,073 | -48.1% | 0.01% | -52.0% |
| Q2 2021 | $236,000 | -7.5% | 5,917 | +4.3% | 0.02% | -21.9% |
| Q1 2021 | $255,000 | -16.4% | 5,671 | +5.1% | 0.03% | -33.3% |
| Q4 2020 | $305,000 | +35.6% | 5,398 | +13.6% | 0.05% | +11.6% |
| Q3 2020 | $225,000 | -13.5% | 4,750 | +7.8% | 0.04% | -31.7% |
| Q2 2020 | $260,000 | +16.1% | 4,408 | -7.2% | 0.06% | -28.4% |
| Q1 2020 | $224,000 | -23.5% | 4,748 | -2.0% | 0.09% | -5.4% |
| Q4 2019 | $293,000 | +24.2% | 4,847 | +23.1% | 0.09% | +14.8% |
| Q3 2019 | $236,000 | -3.3% | 3,938 | +3.7% | 0.08% | -5.8% |
| Q2 2019 | $244,000 | +5.2% | 3,799 | +33.1% | 0.09% | -1.1% |
| Q1 2019 | $232,000 | +26.8% | 2,854 | -15.9% | 0.09% | -1.1% |
| Q4 2018 | $183,000 | +1.1% | 3,393 | -3.4% | 0.09% | +17.3% |
| Q3 2018 | $181,000 | +15.3% | 3,513 | -6.8% | 0.08% | +13.6% |
| Q2 2018 | $157,000 | -1.9% | 3,771 | +3.7% | 0.07% | -23.3% |
| Q1 2018 | $160,000 | -12.1% | 3,638 | +0.4% | 0.09% | -4.4% |
| Q4 2017 | $182,000 | – | 3,623 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |